(6-Benzhydryloxycarbonylamino-purin-9-yl)-acetic acid, 97.0%, 5g

3-CHLORO-4-NITROBENZALDEHYDE, 95.0%, 25g

Ethyl 6-bromo-1H-pyrrolo[2,3-b]pyridine-2-carboxylate, 95.0%, 25g

5-Methoxy-2,3,3-trimethylindoline, 10g

Nitrato de sanguinarina, mínimo 95 %, 10 mg, envase de vidrio

3-Trifluoromethyl-1H-pyrazole-4-boronic acid pinacol ester, 95.0%, 100mg

2-(Aminomethyl)-1-ethylpyrrolidine>98.0%(GC)(T)25g

5-Octyl-4H-thieno[3,4-c]pyrrole-4,6(5H)-dione, 95.0%, 5g

4-(4-Methoxyphenyl)-3-oxobutanenitrile, 95%, 500mg

Tetrakis(dimethylamino)ethylene>95.0%(GC)25g

2,5-Dioxopyrrolidin-1-yl 2-(acetylthio)acetate, 95.0%, 1g

1-Vinylnaphthalene, 95.0%, 5g

N-?[(11bS)?-?2,?6-?Bis[3,?5-?bis(trifluoromethyl)?phenyl]?-?4-?oxido-dinaphtho[2,?1-?d:1',?2'-?f]?[1,?3,?2]?dioxaphosphepin-?4-?yl]?-?1,?1,?1-?trifluoromethanesulfonamide, 97%, 250mg